Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD ; volume:9 ; number:1 ; day:19 ; month:3 ; year:2021 ; pages:1-8 ; date:12.2021
Acta Neuropathologica Communications ; 9, Heft 1 (19.3.2021), 1-8, 12.2021
- Urheber
-
Coyne, Alyssa N.
Rothstein, Jeffrey D.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40478-021-01150-5
- URN
-
urn:nbn:de:101:1-2021050520580588416611
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Coyne, Alyssa N.
- Rothstein, Jeffrey D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features
The nuclear import receptor Kapβ2 modifies neurotoxicity mediated by poly(GR) in C9orf72-linked ALS/FTD
Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD
A familial FTD associated with C9orf72 repeat expansion and dysplastic gangliocytoma
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD
Aktive und passive anti-GA Immuntherapie für C9orf72 ALS/FTD im Mausmodell
RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3
Targeting RNA G‐quadruplexes as new treatment strategy for C9orf72 ALS/FTD
Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies
Phenylalanine-tRNA aminoacylation is compromised by ALS/FTD-associated C9orf72 C4G2 repeat RNA
Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features
The nuclear import receptor Kapβ2 modifies neurotoxicity mediated by poly(GR) in C9orf72-linked ALS/FTD
Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD
A familial FTD associated with C9orf72 repeat expansion and dysplastic gangliocytoma
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD
Aktive und passive anti-GA Immuntherapie für C9orf72 ALS/FTD im Mausmodell
RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3
Targeting RNA G‐quadruplexes as new treatment strategy for C9orf72 ALS/FTD
Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies
Phenylalanine-tRNA aminoacylation is compromised by ALS/FTD-associated C9orf72 C4G2 repeat RNA
Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features
The nuclear import receptor Kapβ2 modifies neurotoxicity mediated by poly(GR) in C9orf72-linked ALS/FTD
Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD
A familial FTD associated with C9orf72 repeat expansion and dysplastic gangliocytoma
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD
Aktive und passive anti-GA Immuntherapie für C9orf72 ALS/FTD im Mausmodell
RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3
Targeting RNA G‐quadruplexes as new treatment strategy for C9orf72 ALS/FTD
Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies